drugset / Trial / NCT06311786
A Study to Look at How a Single Oral Dose of Carbon-14-Labelled [14C] BIIB091 Moves Through and is Processed by the Body in Healthy Male Participants
NaSingle-groupOpen-labelTreatment
Summary
The main goal of this study is to learn how \[14C\]-BIIB091 moves through and is processed by the body and to look at how much of BIIB091's metabolites (what is produced when BIIB091 is broken down by the body) appears in the blood, urine, and stool in healthy male participants. The study will also help researchers learn more about the safety of BIIB091 in healthy male participants.
Timeline
- Start
- 2024-04-08
- Primary completion
- 2024-05-11
- Completion
- 2024-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BIIB091 | Small molecule | — | Oral |
Indications
No indication recorded.